Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir

BACKGROUND: Study C210 was a Phase IIa, exploratory trial to assess the activity of telaprevir on hepatitis C virus (HCV) early viral kinetics in treatment-naïve patients infected with genotype 4 (G4) HCV. METHODS: Patients were randomized to receive peginterferon and ribavirin alone, telaprevir mon...

Descripción completa

Detalles Bibliográficos
Autores principales: De Meyer, Sandra, Ghys, Anne, Dierynck, Inge, Beumont, Maria, Luo, Donghan, Picchio, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030523/
https://www.ncbi.nlm.nih.gov/pubmed/24886541
http://dx.doi.org/10.1186/1743-422X-11-93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030523/
https://www.ncbi.nlm.nih.gov/pubmed/24886541
http://dx.doi.org/10.1186/1743-422X-11-93

Ejemplares similares